LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 229 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,043,147 | +48.3% | 17,409 | +78.4% | 0.00% | 0.0% |
Q2 2023 | $703,480 | +234.7% | 9,757 | +241.5% | 0.00% | – |
Q1 2023 | $210,161 | -12.8% | 2,857 | -20.8% | 0.00% | – |
Q4 2022 | $241,081 | -89.8% | 3,609 | -86.8% | 0.00% | -100.0% |
Q3 2022 | $2,354,000 | -13.9% | 27,345 | -10.7% | 0.00% | 0.0% |
Q2 2022 | $2,734,000 | -20.4% | 30,638 | -9.5% | 0.00% | 0.0% |
Q1 2022 | $3,434,000 | -16.4% | 33,869 | +27.4% | 0.00% | -25.0% |
Q4 2021 | $4,107,000 | -11.5% | 26,586 | -20.2% | 0.00% | -20.0% |
Q3 2021 | $4,642,000 | +1.7% | 33,314 | -4.3% | 0.01% | +25.0% |
Q2 2021 | $4,565,000 | -22.5% | 34,794 | -10.0% | 0.00% | -33.3% |
Q1 2021 | $5,893,000 | +902.2% | 38,658 | +554.2% | 0.01% | +500.0% |
Q4 2020 | $588,000 | -97.6% | 5,909 | -97.7% | 0.00% | -96.9% |
Q3 2020 | $24,563,000 | -19.5% | 257,691 | -5.5% | 0.03% | -22.0% |
Q2 2020 | $30,516,000 | -28.7% | 272,831 | -53.6% | 0.04% | +13.9% |
Q1 2020 | $42,788,000 | +35.7% | 588,396 | +94.6% | 0.04% | -5.3% |
Q4 2019 | $31,531,000 | -22.3% | 302,333 | -25.9% | 0.04% | -26.9% |
Q3 2019 | $40,588,000 | -39.4% | 407,753 | -30.5% | 0.05% | -61.5% |
Q2 2019 | $66,987,000 | -18.7% | 586,835 | -10.5% | 0.14% | -28.2% |
Q1 2019 | $82,428,000 | +29.3% | 655,690 | +39.6% | 0.19% | +17.5% |
Q4 2018 | $63,725,000 | -47.0% | 469,600 | +7.2% | 0.16% | -35.5% |
Q3 2018 | $120,260,000 | +8.0% | 438,125 | -18.5% | 0.25% | +4.6% |
Q2 2018 | $111,324,000 | +32.1% | 537,355 | +5.3% | 0.24% | +28.8% |
Q1 2018 | $84,277,000 | +16.6% | 510,280 | -3.3% | 0.18% | +21.1% |
Q4 2017 | $72,273,000 | -19.7% | 527,812 | -20.2% | 0.15% | -24.8% |
Q3 2017 | $90,032,000 | +9.2% | 661,270 | -2.6% | 0.20% | +4.7% |
Q2 2017 | $82,424,000 | +14.2% | 678,945 | -0.5% | 0.19% | +12.2% |
Q1 2017 | $72,205,000 | -26.4% | 682,210 | -29.3% | 0.17% | -30.4% |
Q4 2016 | $98,081,000 | +2.2% | 965,262 | +2.7% | 0.25% | -8.2% |
Q3 2016 | $95,949,000 | +145277.3% | 940,127 | +168987.6% | 0.27% | – |
Q2 2016 | $66,000 | +94.1% | 556 | +76.5% | 0.00% | – |
Q1 2016 | $34,000 | -44.3% | 315 | -44.0% | 0.00% | – |
Q4 2015 | $61,000 | +22.0% | 563 | -2.9% | 0.00% | – |
Q3 2015 | $50,000 | -23.1% | 580 | -10.8% | 0.00% | – |
Q2 2015 | $65,000 | – | 650 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $6,891 | 2.63% |
VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |